Mitogen-activated protein kinase cascade in breast cancer

Oncology

Volumn 57, Issue SUPPL. 2, 1999, Pages 37-44

  Maemura, Michio ^a   Iino, Yuichi ^a   Koibuchi, Yukio ^a   Yokoe, Takao ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Antiestrogen; Breast cancer; Cell proliferation; Estrogen; Mitogen activated protein kinase; Raf 1

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTIESTROGEN; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; RAF PROTEIN; TAMOXIFEN;

BREAST CANCER; CONFERENCE PAPER; ENZYME PHOSPHORYLATION; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MITOGENS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RATS; TAMOXIFEN;

EID: 0032718656     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055273     Document Type: Conference Paper

References (50)

1. Levitzki A: Targeting signal transduction for disease therapy. Curr Opin Cell Biol 1996;8: 239-244.
2. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD: ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991;65:663-675.
3. Bogoyevitch MA, Ketterman AJ, Sugden PH: Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 1995;270: 29710-29717.
4. Han J, Lee JD, Bibbs L, Ulevitch RJ: A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994;265: 808-811.
5. Vojtek AB, Hollenberg SM, Cooper JA: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 1993;74:205-214.
6. Howe LR, Leevers SJ, Gomez N, Nakielny S, Cohen P, Marshall CJ: Activation of the MAP kinase pathway by the protein kinase raf. Cell 1992;71:335-342.
7. Macdonald SG, Crews CM, Wu L, Driller J, Clark R, Erikson RL, McCormick F: Reconstitution of the Raf-1-MEK-ERK signal transduction pathway in vitro. Mol Cell Biol 1993;13: 6615-6620.
8. Gomez N, Cohen P: Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 1991;353:170-173.
9. Chen RH, Sarnecki C, Blenis: Nuclear localization and regulation of erk- and rsk-encoded protein kinases. J Mol Cell Biol 1992;12:915-927.
10. Hill CS, Marais R, John S, Wynne J, Dalton S, Treisman R: Functional analysis of a growth factor-responsive transcription factor complex. Cell 1993;73:395-406.
11. Dickson RB, Lippman ME: Growth factors in breast cancer. Endocr Rev 1995;16:559-589.
12. Jordan VC, Murphy CS: endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 1990;11:578-610.
13. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV: Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 1997; 236:54-58.
14. Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, Yamamoto H, Fujimoto J, Okamoto E, Hayashi N, Hori M: Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 1998;27:951-958.
15. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995; 55:4182-4187.
16. Bang YJ, Kwon JH, Kang SH, Kim JW, Yang YC: Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun 1998;250: 43-47.
17. Ostrowski J, Trzeciak L, Kolodziejski J, Bomsztyk K: Increased constitutive activity of mitogen-activated protein kinase and renaturable 85 kDa kinase in human-colorectal cancer. Br J Cancer 1998;78:1301-1306.
18. Sivaraman VS, Wang H, Nuovo GJ, Malbon CC: Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997;99:1478-1483.
19. Atten MJ, Attar BM, Holian O: Decreased MAP kinase activity in human gastric adenocarcinoma. Biochem Biophys Res Commun 1995;212:1001-1006.
20. Sun H, Tonks NK, Bar-Sagi D: Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 1994;266: 285-288.
21. Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M: Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab Invest 1997;76:37-51.
22. Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, Wang Y, Magi-Galluzzi C, Stork PJ: Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol 1996;149:1553-1564.
23. mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 1993;90:8319-8323.
24. Wagner M, Lopez ME, Cahn M, Korc M: Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. Gastroenterology 1998;114: 798-807.
25. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966-970.
26. Brunet A, Pages G, Pouyssegur J: Constitutively active mutants of the MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 1994;9:3379-3387.
27. Goke M, Kanai M, Lynch-Devaney K, Podolsky DK: Rapid mitogen-activated protein kinase activation by transforming growth factor alpha in wounded rat intestinal epithelial cells. Gastroenterology 1998;114:697-705.
28. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, Schmidt-Ullrich R, Mikkelsen R, Dent P: Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 1998;16:2787-2796.
29. El-Ashry D, Miller DL, Kharbanda S, Lippman ME, Kern FG: Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis. Oncogene 1997;15:423-435.
30. Janes PW, Daly RJ, deFazio A, Sutherland RL: Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 1994;9:3601-3608.
31. Liu ML, Von Lintig FC, Liyanage M, Shibata MA, Jorcyk CL, Ried T, Boss GR, Green JE: Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice. Oncogene 1998;17:2403-2411.
32. Amundadottir LT, Leder P: Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 1998;16:737-746.
33. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-27494.
34. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-7689.
35. Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ: Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene 1998;16:2803-2813.
36. Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F: Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-1300.
37. Beno DW, Brady LM, Bissonnette M, Davis BH: Protein kinase C and mitogen-activated protein kinase are required for 1,25-dihydroxy-vitamin D3-stimulated Egr induction. J Biol Chem 1995;270:3642-3647.
38. Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL, Nicholson RI: Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J Natl Cancer Inst 1995; 87:746-750.
39. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-185.
40. Liu JF, Issad T, Chevet E, Ledoux D, Courty J, Caruelle JP, Barritault D, Crepin M, Bertin B: Fibroblast growth factor-2 has opposite effects on human breast cancer MCF-7 cell growth depending on the activation level of the mitogen-activated protein kinase pathway. Eur J Biochem 1998;258:271-276.
41. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, Taverna D: NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene 1995;10:167-175.
42. Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of the MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994;77:841-852.
43. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, Nelkin BD, Mabry M: Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 1998;101:153-159.
44. Pumiglia KM, Decker SJ: Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997; 94:448-452.
45. Kerkhoff E, Rapp UR: High-intensity Raf signals convert mitotic cell cycling into cellular growth. Cancer Res 1998;58:1636-1640.
46. Whalen AM, Galasinski SC, Shapiro PS, Nahreini TS, Ahn NG: Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol 1997;17:1947-1958.
47. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, et al: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995;270:1491-1494.
48. Johnson MR, Valentine C, Basilico C, Mansukhani A: FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene 1998;16: 2647-2656.
49. Bunone G, Briand PA, Miksicek RJ, Picard D: Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 1996;15: 2174-2183.
50. Coutts AS, Murphy LC: Elevated mitogen-activated protein kinase activity in estrogen-non-responsive human breast cancer cells. Cancer Res 1998;58:4071-4074.